The Leukemia Lymphoma Society S Therapy Acceleration

The Leukemia Lymphoma Society S Therapy Acceleration Program vs Jonathan S Wang

The Leukemia Lymphoma Society S Therapy Acceleration Program is a venture capital based in New York, New York, United States. Jonathan S Wang is a private equity based in New York across 63 portfolio companies. Sector focus diverges: The Leukemia Lymphoma Society S Therapy Acceleration Program concentrates on generalist deals and Jonathan S Wang on Proptech.

• Investor type: The Leukemia Lymphoma Society S Therapy Acceleration Program — Venture Capital; Jonathan S Wang — Private Equity
• Headquarters: The Leukemia Lymphoma Society S Therapy Acceleration Program — New York, New York, United States; Jonathan S Wang — New York
• Portfolio companies: The Leukemia Lymphoma Society S Therapy Acceleration Program — not disclosed; Jonathan S Wang — 63
• Sectors: The Leukemia Lymphoma Society S Therapy Acceleration Program — not disclosed; Jonathan S Wang — Proptech

• The Leukemia & Lymphoma Society’s Therapy Acceleration Program — Venture Capital · New York, New York, United States · The Leukemia Lymphoma Society S Therapy Acceleration Program portfolio
• Jonathan S. Wang — Private Equity · New York · 63 tracked deals · Jonathan S Wang portfolio

Similar investors

• Timothy Huang
• Christopher Walsh
• Daniel Fabian
• Steven G. Glenn
• Strategic Equity Capital NY LLC
• Governors Lane Fund General Partner LLC
• Marc K. Furstein
• Victor L. Wu
• Edward Tsai
• iCapital Strategies LLC

Investors like The Leukemia Lymphoma Society S Therapy Acceleration Program · Investors like Jonathan S Wang · The Leukemia Lymphoma Society S Therapy Acceleration Program co-investors · Full investor directory